Drug Shortage Report for AMIODARONE HYDROCHLORIDE FOR INJECTION

Last updated on 2021-03-08 History
Report ID 133022
Drug Identification Number 02242325
Brand name AMIODARONE HYDROCHLORIDE FOR INJECTION
Common or Proper name AMIODARONE HYDROCHLORIDE FOR INJECTION
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) AMIODARONE HYDROCHLORIDE
Strength(s) 50MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 18ML 1LIVI CA
ATC code C01BD
ATC description ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-01-29
Estimated end date 2021-03-05
Actual end date 2021-03-05
Shortage status Resolved
Updated date 2021-03-08
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-03-08 French Compare
v3 2021-03-08 English Compare
v2 2021-02-01 French Compare
v1 2021-02-01 English Compare